Recurrent Stroke in the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

Publisher： Karger

E-ISSN： 1421-9786|38|3|176-181

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.38, Iss.3, 2014-10, pp. : 176-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stroke in Heart Failure in Sinus Rhythm: The Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction Trial

By  

Cerebrovascular Diseases, Vol. 36, Iss. 1, 2013-07 ,pp. : 74-78

Karger

Access to resources Recommend Favorite

Comparison of Warfarin versus Aspirin for the Prevention of Recurrent Stroke or Death: Subgroup Analyses from the Warfarin-Aspirin Recurrent Stroke Study

By  

Cerebrovascular Diseases, Vol. 22, Iss. 1, 2006-04 ,pp. : 4-12

Karger

Access to resources Recommend Favorite

Left Ventricular Geometry and Risk of Sudden Cardiac Arrest in Patients With Severely Reduced Ejection Fraction

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 8, 2016-08 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis

By  

Neuroepidemiology, Vol. 22, Iss. 2, 2003-03 ,pp. : 106-117

Karger

Access to resources Recommend Favorite

Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Stroke in Patients with a History of Atrial Fibrillation: Subgroup Analysis of the CHARISMA Randomized Trial

By  

Cerebrovascular Diseases, Vol. 25, Iss. 4, 2008-02 ,pp. : 344-347

Karger

Access to resources Recommend Favorite